Imidazolopiperazines: lead optimization of the second-generation antimalarial agents

Area of Science:

• Medicinal Chemistry
• Parasitology
• Pharmacology

Background:

• Imidazolopiperazines represent a promising class of compounds for antimalarial drug development.
• Previous optimization efforts yielded initial success, necessitating further structural modifications.

Purpose of the Study:

• To synthesize and evaluate a second generation of imidazolopiperazine analogues with improved antimalarial properties.
• To enhance compound potency and metabolic stability through modifications of the piperazine ring.
• To assess the in vivo efficacy and pharmacokinetic profile of optimized compounds.

Main Methods:

• Synthesis of novel 8,8-dimethyl imidazolopiperazine analogues.
• In vitro metabolic identification studies to guide structural modifications.
• In vivo antimalarial efficacy testing in a malaria mouse model.
• Pharmacokinetic studies in rats to evaluate oral exposure.

Main Results:

• The optimized 8,8-dimethyl imidazolopiperazine analogues demonstrated enhanced potency and improved in vitro metabolic stability.
• These compounds exhibited superior efficacy compared to existing antimalarials in a malaria mouse model.
• Pharmacokinetic studies revealed moderate oral exposure in rats, sufficient for toxicology assessments.

Conclusions:

• Second-generation imidazolopiperazines with modifications to the piperazine ring show significant promise as antimalarial agents.
• The optimized compounds possess improved potency, metabolic stability, and in vivo efficacy.
• Further development of these compounds is warranted based on their enhanced antimalarial profile.